Trial Profile
Effect of dimethyl fumarate (Tecfidera) on the association between fatigue and fatigability in relapsing-remitting MS patients
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2018
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 18 May 2018 New trial record